Description
Recombinant monoclonal antibody can specifically bind TPO outside the immunodominant region. This human anti-non-IDR antibody TF3.5 can be potentially used in the treatment of patients with TPO autoantibody-positive Graves.
Target
TPO
Target Alias Names
MSA, TPX, TDH2A
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression